A new activated factor X-based clotting method with improved specificity for procoagulant phospholipid

被引:52
|
作者
Exner, T [1 ]
Joseph, J [1 ]
Low, J [1 ]
Connor, D [1 ]
Ma, D [1 ]
机构
[1] St Vincents Hosp, Dept Haematol, Darlinghurst, NSW 2010, Australia
关键词
phospholipid; procoagulants; platelets; microparticles; lupus anticoagulant; activated factor X; clotting test;
D O I
10.1097/00001721-200312000-00015
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
An improved activated factor X-based clotting method was used to investigate activity of procoagulant phospholipid (PPL) in blood samples collected into various anticoagulants and in plasmas with a range of abnormalities. The dilute activated factor X-activated clotting time (XACT) was carried out on a mixture of specimen with phospholipid-free porcine plasma. PPL from the test sample is then rate-limiting, controlling the clotting time so that the XACT is shortened from a maximum of approximately 120 s with citrated platelet-free plasma to approximately 30 s with freeze-thawed platelet-rich plasma. XACT results were only shortened slightly by fresh normal platelet-rich plasma, but were shortened significantly by platelets that had been activated by freeze-thawing. This improved method for PPL was not prolonged by deficiencies of known clotting factors and therapeutic levels of heparin, and it was surprisingly resistant to most lupus anticoagulants. However, it was extremely sensitive to PPL, detecting down to 50 ng/ml synthetic phospholipid added to phospholipid-free plasma. Excellent correlation was achieved between XACT shortening and microparticle count assessed by annexin V-binding and flow cytometry in normal plasma spiked with platelet microparticles. In citrated blood specimens, XACT shortened with time in a temperature-dependent manner. XACT results on blood samples anticoagulated with ethylenediamine tetra-acetate were more stable, and these would be preferable for assessing PPL expression ex vivo. XACT was significantly shorter in whole blood samples than in normal platelet-rich or platelet-poor plasmas, suggesting that PPL was normally expressed more by cells or aggregates larger than platelets or microparticles. (C) 2003 Lippincott Williams Wilkins.
引用
收藏
页码:773 / 779
页数:7
相关论文
共 50 条
  • [1] Activated factor X-based assay for the detection of procoagulant phospholipid activity in patients with cancer and/or venous thromboembolism
    Radu, C. M.
    Spiezia, L.
    Campello, E.
    Gavasso, S.
    Carraro, S.
    Ferri, V
    Woodhams, B.
    Simioni, P.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 : 186 - 186
  • [2] Activated Factor X-Based versus Thrombin-Based Antithrombin Testing in Thrombophilia Workup in the DOAC Era
    Ruehl, Heiko
    Reda, Sara
    Mueller, Jens
    Oldenburg, Johannes
    Poetzsch, Bernd
    THROMBOSIS AND HAEMOSTASIS, 2018, 118 (02) : 381 - 387
  • [3] AN HEPATIC INHIBITOR OF ACTIVATED CLOTTING FACTOR X (STUART)
    DEYKIN, D
    COCHIOS, F
    MOSHER, D
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1969, 34 (02) : 245 - &
  • [4] Surprising phospholipid specificity of two blood clotting proteins: factor VII and protein C
    Tavoosi, Narjes
    Morrissey, James H.
    FASEB JOURNAL, 2013, 27
  • [5] SIMPLE AND RAPID METHOD TO DETERMINE THE BINDING OF BLOOD-CLOTTING FACTOR-X TO PHOSPHOLIPID-VESICLES
    VANDIEIJEN, G
    TANS, G
    VANRIJN, J
    ZWAAL, RFA
    ROSING, J
    BIOCHEMISTRY, 1981, 20 (25) : 7096 - 7101
  • [6] A NEW METHOD TO DETERMINE THE BINDING OF FACTOR-X TO PHOSPHOLIPID-BILAYERS
    TANS, G
    ROSING, J
    VONDIEIJEN, G
    VONRIJN, J
    HEMKER, HC
    THROMBOSIS AND HAEMOSTASIS, 1981, 46 (01) : 89 - 89
  • [7] Procoagulant Phospholipid Dependent Clotting Time: A New Tool for the Identification of Multiple Myeloma Patients at Risk Poor Treatment Response
    Despina, Fotiou
    Papageorgiou, Loula
    Salta, Stella
    Van Dreden, Patrick
    Terpos, Evangelos
    Fareed, Jawed
    Grusse, Matthieu
    Elalamy, Ismail
    Garderet, Laurent
    Mazurier, Christelle
    Gerotziafas, Grigorios T.
    BLOOD, 2017, 130
  • [8] The effect of factor X level on thrombin generation and the procoagulant effect of activated factor VII in a cell-based model of coagulation
    Allen, GA
    Monroe, DM
    Roberts, HR
    Hoffman, M
    BLOOD COAGULATION & FIBRINOLYSIS, 2000, 11 : S3 - S7
  • [9] INACTIVATION OF BOVINE ACTIVATED CLOTTING FACTOR X(XA) IN CULTURED RAT HEPATOCYTES
    QURESHI, GD
    SUN, M
    GAINES, JP
    THROMBOSIS AND HAEMOSTASIS, 1985, 54 (01) : 291 - 291
  • [10] A NEW CHROMOGENIC SUBSTRATE FOR THE DETERMINATION OF CLOTTING FACTOR-X
    SCHIFFERS, PMH
    DEMETZ, M
    VANWERSCH, JWJ
    JOURNAL OF CLINICAL CHEMISTRY AND CLINICAL BIOCHEMISTRY, 1986, 24 (10): : 796 - 797